Visby Medical’s VC round swells to $135M to add new tests to handheld PCR platform | Fierce Biotech

Funding & venture capital News

The cherry on top of that $100 million megaround is an extra dollop of venture capital that brings its final total to more than $135 million, ...

Related articles